Compositions for treating mammalian diseases caused by inflammatory response

摘要

Described is the use in the manufacture of a medicament, of an inflammatory response mediator selected from a pyruvate precursor, pyruvate, a lactate precursor, and lactate, and a carrier composition for reducing and treating an airway disease state in mammals caused by undesired inflammatory response.